Construction of a circRNA-miRNA-mRNA Regulatory Network for the Immune Regulation of Lung Adenocarcinoma

Hanyi Li1,2, Xin Jin1,2, Wei Li1,2

  • 1Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.

PubMed
Abstract

Insights

Circular RNAs (circRNAs) regulate non-small cell lung cancer (NSCLC) progression and immune responses. This study identified a novel circRNA-miRNA-mRNA network in lung adenocarcinoma (LUAD), with hsa_circ_0079557 knockdown inhibiting LUAD cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Circular RNAs (circRNAs) are key regulators in tumor progression and therapy response in non-small cell lung cancer (NSCLC).
  • circRNAs modulate mRNA expression via microRNA (miRNA) sponging.
  • The circRNA-miRNA-mRNA network's role in lung adenocarcinoma (LUAD) immune regulation is unclear.

Purpose of the Study:

  • To elucidate the circRNA-miRNA-mRNA regulatory network in LUAD immune responses.
  • To identify key molecular players and pathways involved in LUAD immune regulation.

Main Methods:

  • Microarray data (GSE101586) identified differentially expressed circRNAs (DEcircRNAs) in LUAD.
  • circRNA-miRNA-mRNA interactions were predicted and intersected with immune genes (IMMPORT).
  • Protein-protein interaction networks, functional enrichment (DAVID), and immune cell infiltration analyses (ssGSEA, CIBERSORT) were performed. In vitro experiments validated a key circRNA.

Main Results:

  • Identified 7 upregulated and 42 downregulated circRNAs, 10 miRNAs, and 20 target mRNAs.
  • Enrichment analysis highlighted the ErbB signaling pathway and immune-related functions (cytokine signaling).
  • A regulatory network of 6 DEcircRNAs, 3 DEmiRNAs, and 3 DEmRNAs was constructed. Knockdown of hsa_circ_0079557 inhibited LUAD cell proliferation and invasion, with altered immune cell infiltration observed.

Conclusions:

  • Established a novel circRNA-miRNA-mRNA network providing insights into LUAD immune regulation.
  • Findings offer potential therapeutic targets for LUAD treatment.
  • Further research is needed to translate these discoveries into clinical applications for improved patient outcomes.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K